StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Currency Impact on Core Operating Income Growth by Quarter

Currency Impact on Core Operating Income Growth (percentage points) (%)

Novartis Currency Impact on Core Operating Income Growth: 1.0% in Q3 2026, up 2.0 pts from a year earlier.

Latest, Q3 2026
1.0%
Period ended Sep 30, 2026
Change on a year earlier
+2.0 pts
-1.0% in Q3 2025
History
21 quarters
Since Q1 2020
Sources
21
Documents cited below

Where the Q3 2026 figure comes from

“|| Core operating income | 11 | 10 | 1”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCurrency Impact on Core Operating Income Growth (percentage points) (%)Year on yearSource
Q3 2026Sep 30, 20261.0%+2.0 ptsNovartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20260.0%+1.0 ptsNovartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 20262.0%+6.0 ptsNovartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20250.0%–Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025-1.0%–Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 2025-1.0%–Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2025Mar 31, 2025-4.0%–Novartis Form 6-K (0001370368-25-000010) ↗
Q2 2023Jun 30, 2023-8.0%-3.0 ptsNovartis Form 6-K (0001370368-23-000059) ↗
Q1 2023Mar 31, 2023-5.0%0.0 ptsNovartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 2022-8.0%-8.0 ptsNovartis Form 6-K (0001370368-23-000008) ↗
Q3 2022Sep 30, 2022-7.0%-9.0 ptsNovartis Form 6-K (0001370368-22-000077) ↗
Q2 2022Jun 30, 2022-5.0%-11.0 ptsNovartis Form 6-K (0001370368-22-000059) ↗
Q1 2022Mar 31, 2022-5.0%-6.0 ptsNovartis Form 6-K (0001370368-22-000038) ↗
Q4 2021Dec 31, 20210.0%+1.0 ptsNovartis Form 6-K (0001370368-22-000009) ↗
Q3 2021Sep 30, 20212.0%+3.0 ptsNovartis Form 6-K (0001370368-21-000072) ↗
Q2 2021Jun 30, 20216.0%+12.0 ptsNovartis Form 6-K (0001370368-21-000055) ↗

Cite this data

StockData. (2026). Novartis Currency Impact on Core Operating Income Growth (%), quarterly Q1 2020–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/fx-impact-core-opinc-pp

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.